Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20674008.
- Also identified by DOI 10.1016/j.biomaterials.2010.07.010 and PMC identifier 2924947.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Angiogenesis is an organized series of events, beginning with vessel destabilization, followed by endothelial cell re-organization, and ending with vessel maturation. Vascular endothelial growth factor (VEGF) aids in vascular permeability and endothelial cell recruitment while sphingosine 1-phosphate (S1P) stimulates vascular stability. Accordingly, VEGF may inhibit vessel stabilization while S1P may inhibit endothelial cell recruitment. For this reason, we created a new externally-regulated delivery model that not only permits sustained release of bioactive factors, but also temporal separation of the delivery of growth factors. Using this model, sequential delivery of factors was first confirmed in vitro with associated endothelial cells responding in a dose dependent manner. Furthermore, using a modified murine Matrigel plug model, it is apparent that delivery strategies where VEGF presentation is temporally separated from S1P presentation not only led to greater recruitment of endothelial cells, but also higher maturation index of associated vessels.
Medical subject headings
- Delayed-Action Preparations
- Drug Delivery Systems
- Lysophospholipids
- Neovascularization, Physiologic
- Sphingosine
- Vascular Endothelial Growth Factor A